Browse by Phase
Phase 2 / Phase 3 Clinical Trials
Phase 2/3 combined trials bridge efficacy assessment and large-scale comparison, enrolling larger cohorts while still gathering dose-response data.
Total Trials
104
Recruiting Now
104
Top Conditions in Phase 2 / Phase 3
NCT06821295 Phase 2, Phase 3
Recruiting
Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencin...
Condition
Alcohol Misuse
Enrollment
600 pts
Location
United States
Sponsor
University of Oklahoma
NCT07454837 Phase 2, Phase 3
Recruiting
Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in...
Condition
Chronic Hepatitis D
Enrollment
120 pts
Location
Romania, United Kingdom
Sponsor
Mirum Pharmaceuticals, Inc.
NCT05065957 Phase 2, Phase 3
Recruiting
Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subje...
Condition
Biliary Tract Cancer
Enrollment
180 pts
Location
Taiwan
Sponsor
InnoPharmax Inc.
NCT04329364 Phase 2, Phase 3
Recruiting
RCT Comparing Conventional Haemorrhoidectomy With Laser Haemorrhoidoplasty
Condition
Hemorrhoids
Enrollment
128 pts
Location
Singapore
Sponsor
Sengkang General Hospital
NCT07221149 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Che...
Condition
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Enrollment
690 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT06834932 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Par...
Condition
Dyslipidaemia
Enrollment
360 pts
Location
China, Hong Kong
Sponsor
AstraZeneca
NCT04749108 Phase 2, Phase 3
Recruiting
Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma
Condition
Locally Advanced Malignant Neoplasm
Enrollment
1,075 pts
Location
France
Sponsor
Institut du Cancer de Montpell
NCT05768178 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in...
Condition
Haematological Malignancy
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT03534050 Phase 2, Phase 3
Recruiting
Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Unde...
Condition
Glioma of Brain
Enrollment
80 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT07092618 Phase 2, Phase 3
Recruiting
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GL...
Condition
Longevity
Enrollment
150 pts
Location
United States
Sponsor
AgelessRx
NCT03373968 Phase 2, Phase 3
Recruiting
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability St...
Condition
Duchenne Muscular Dystrophy
Enrollment
206 pts
Location
United States, Belgium, Canada
Sponsor
Italfarmaco
NCT05381103 Phase 2, Phase 3
Recruiting
PSMA-PET to Guide Prostatectomy
Condition
Prostate Cancer
Enrollment
288 pts
Location
United States
Sponsor
Five Eleven Pharma, Inc.
NCT04047576 Phase 2, Phase 3
Recruiting
Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis
Condition
Retroperitoneal Fibrosis
Enrollment
60 pts
Location
China
Sponsor
Peking University Internationa
NCT07221682 Phase 2, Phase 3
Recruiting
Comparison of Supra vs Infra Inguinal Fascia Iliaca Blocks for Spinal Positionin...
Condition
Post Operative Analgesia
Enrollment
60 pts
Location
Pakistan
Sponsor
Sahiwal medical college sahiwa
NCT07112196 Phase 2, Phase 3
Recruiting
Visugromab in Cachexia International Trial
Condition
Cancer-associated Cachexia
Enrollment
518 pts
Location
United States
Sponsor
CatalYm GmbH
NCT05433350 Phase 2, Phase 3
Recruiting
Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Aco...
Condition
Trypanosomiasis, African
Enrollment
35 pts
Location
Democratic Republic of the Congo, Guinea
Sponsor
Drugs for Neglected Diseases
NCT07202091 Phase 2, Phase 3
Recruiting
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immuno...
Condition
Myeloma
Enrollment
900 pts
Location
Australia
Sponsor
Monash University
NCT05991388 Phase 2, Phase 3
Recruiting
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refract...
Condition
B-cell Non Hodgkin Lymphoma
Enrollment
210 pts
Location
Australia, Austria, Belgium
Sponsor
University of Birmingham
NCT04499898 Phase 2, Phase 3
Recruiting
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophagea...
Condition
Esophageal Varices
Enrollment
306 pts
Location
Egypt
Sponsor
Sherief Abd-Elsalam
NCT05535738 Phase 2, Phase 3
Recruiting
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflamm...
Condition
Skin Inflammation
Enrollment
45 pts
Location
United States
Sponsor
Wei-Che Ko
NCT05543616 Phase 2, Phase 3
Recruiting
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Heal...
Condition
SARS-CoV-2 Virus
Enrollment
4,292 pts
Location
United States, Brazil, Puerto Rico
Sponsor
BioNTech SE
NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care i...
Condition
DLBCL
Enrollment
290 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06910579 Phase 2, Phase 3
Recruiting
Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers
Condition
Aphthus Ulcer
Enrollment
30 pts
Location
Egypt
Sponsor
British University In Egypt
NCT05474846 Phase 2, Phase 3
Recruiting
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced...
Condition
Sleep
Enrollment
188 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT07389616 Phase 2, Phase 3
Recruiting
A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Pro...
Condition
Peripheral T Cell Lymphoma
Enrollment
40 pts
Location
China
Sponsor
Shanghai General Hospital, Sha